3篇
您的检索式：作者名="Altaf Mangera"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 膀胱过度活动症:发病机制及治疗现状显示文摘内容摘要OAB为一类发病率较高的慢性疾病,严重影响患者的生活质量,给个人及社会带来了巨大的经济负担。OAB为基于症候群进行诊断的综合征,定义为“尿急,伴或不伴急迫性尿失禁,常伴有尿频和夜尿症状”。OAB无明确的病因,不包括由急性尿路感染或其他形式的膀胱尿道局部病变所致的症状。OAB的核心症状为尿急,尿急是指一种突发、强烈的排尿欲望,且很难被主观抑制而延迟排尿。 | Nadir I. Osman Altaf Mangera Christopher R. Chapple 廖利民 | 2012 | 中华泌尿外科杂志2012，33，9： | 10 |
| 2 | Tissue engineering in urethral reconstruction--an update显示文摘织物工程的地很快正在进行。许多工作开始了开发纸巾设计尿道的接枝。当前的接枝长,能创造起始的施主地点病态。在这篇文章,我们评估在发现纸巾为人的尿道设计了代用品取得的进步。研究人员们调查了没有房间、播种房间的接枝。我们讨论不同途径到开发这些接枝并且在人的研究考察他们的报导成功。与进一步的工作,织物设计了接枝可以便于要求口头的 mucosa 替换 urethroplasty 的过长的尿道的苛评的管理。 | Altaf Mangera Christopher R Chapple | 2013 | Asian Journal of Andrology2013，15，1： | 8 |
| 3 | Update summarising the conclusions of the international consultation on male lower urinary tract symptoms显示文摘The International Consultation on Urological Disease have recently published comprehensive conclusions, based on evidence reviewed by eight committees, on aspects of male lower urinary tract symptoms(LUTS). In this review, we summarise the conclusions from fourof the committees, namely, the evidence regarding the epidemiology of male LUTS, patient assessment, nocturia and medical management. It is indisputable that with an expanding and ageing global population the prevalence of male LUTS is likely to increase. Therefore symptom prevention and preservation of quality of life(Qo L) feature highly in the guidelines. There are now a number of different medical options, proven to lead to significant improvements in symptom scores, flow rate and Qo L available to men with LUTS. Metaanalyses have shown the benefits for alpha blockers, antimuscarinics, 5-α reductase and phosphodiesterase-5 inhibitors. High level evidence also exists for combinations of all of the above with alpha blockers and so men with concomitant storage symptoms, prostate volume > 30 mL, PSA > 1.4 or erectile dysfunction may be considered for combination treatment of an alpha blocker with an antimuscarinic, 5-α reductase inhibitor or phosphodiesterase-5 inhibitor respectively. In an era of personalised medicine, appropriate patient selection is likely to provide the key to the most effective clinical management strategy. | Altaf Mangera Christopher Chapple | 2015 | World Journal of Clinical Urology2015，4，2： | 7 |
您所在的机构暂未开通此部分的功能，请联系管理员